For example, TGFβ1, first described as a transforming growth factor, is also a potent growth inhibitor at benign stages of cancer and promotes metastasis, genetic heterogeneity, and drug resistance in aggressive carcinomas8,9,13,14. The gene discussed is TGFB1; the disease is cancer.